ANI Pharmaceuticals, Inc. ANIP
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-11T03:49:22.915Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T21:00:07.302995566Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T03:49:22.287283+00:00
ANI Pharmaceuticals, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 103.40 | 222.1% | 48.6% | |||
| 25Δ | 88.25 | 160.8% | 27.3% | 66.47 | 64.3% | 8.4% |
| 30Δ | 81.11 | 123.0% | 17.3% | 67.62 | 62.1% | 7.2% |
| 35Δ | 77.32 | 99.2% | 12.0% | 68.77 | 60.0% | 6.0% |
| 40Δ | 74.70 | 81.2% | 8.3% | 69.92 | 57.8% | 4.8% |
| 45Δ | 73.68 | 71.7% | 6.9% | 70.69 | 55.8% | 4.2% |
| 50Δ | 72.67 | 62.2% | 5.5% | 71.42 | 53.8% | 3.6% |
| 55Δ | 71.65 | 52.7% | 4.0% | 72.16 | 51.8% | 3.1% |
| 60Δ | 70.64 | 43.2% | 2.6% | 72.90 | 49.8% | 2.5% |
| 65Δ | 73.64 | 47.8% | 2.0% | |||
| 70Δ | 74.38 | 45.9% | 1.4% | |||
| 75Δ | 75.28 | 44.9% | 1.0% | |||
| 80Δ | 77.11 | 49.6% | 0.7% | |||
20Δ
- Pseudo strike
- 103.40
- IV
- 222.1%
- B/E move
- 48.6%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 88.25
- IV
- 160.8%
- B/E move
- 27.3%
- Pseudo strike
- 66.47
- IV
- 64.3%
- B/E move
- 8.4%
30Δ
- Pseudo strike
- 81.11
- IV
- 123.0%
- B/E move
- 17.3%
- Pseudo strike
- 67.62
- IV
- 62.1%
- B/E move
- 7.2%
35Δ
- Pseudo strike
- 77.32
- IV
- 99.2%
- B/E move
- 12.0%
- Pseudo strike
- 68.77
- IV
- 60.0%
- B/E move
- 6.0%
40Δ
- Pseudo strike
- 74.70
- IV
- 81.2%
- B/E move
- 8.3%
- Pseudo strike
- 69.92
- IV
- 57.8%
- B/E move
- 4.8%
45Δ
- Pseudo strike
- 73.68
- IV
- 71.7%
- B/E move
- 6.9%
- Pseudo strike
- 70.69
- IV
- 55.8%
- B/E move
- 4.2%
50Δ
- Pseudo strike
- 72.67
- IV
- 62.2%
- B/E move
- 5.5%
- Pseudo strike
- 71.42
- IV
- 53.8%
- B/E move
- 3.6%
55Δ
- Pseudo strike
- 71.65
- IV
- 52.7%
- B/E move
- 4.0%
- Pseudo strike
- 72.16
- IV
- 51.8%
- B/E move
- 3.1%
60Δ
- Pseudo strike
- 70.64
- IV
- 43.2%
- B/E move
- 2.6%
- Pseudo strike
- 72.90
- IV
- 49.8%
- B/E move
- 2.5%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 73.64
- IV
- 47.8%
- B/E move
- 2.0%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 74.38
- IV
- 45.9%
- B/E move
- 1.4%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 75.28
- IV
- 44.9%
- B/E move
- 1.0%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 77.11
- IV
- 49.6%
- B/E move
- 0.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 37.84% | |
| 37.24% | |
| 40.62% | |
| 34.26% | |
| 34.90% | |
| 35.39% | |
| 34.29% | |
| 35.86% | |
| 36.05% | |
| 36.35% | |
| 37.39% | |
| 35.84% | |
| 37.75% | |
| 39.08% | |
| 40.47% | |
| 40.39% | |
| 43.92% | |
| 48.14% | |
| 46.97% | |
| 56.25% | |
| 36.81% | |
| 36.54% | |
| 35.53% | |
| 36.13% | |
| 37.38% | |
| 36.76% | |
| 34.51% | |
| 37.59% | |
| 39.07% | |
| 37.21% | |
| 37.14% | |
| 36.61% | |
| 40.13% | |
| 38.64% | |
| 38.11% | |
| 38.73% | |
| 39.13% | |
| 39.65% | |
| 39.55% | |
| 39.75% | |
| 40.62% | |
| 40.19% | |
| 40.75% | |
| 40.67% | |
| 41.54% |
Drug Manufacturers - Specialty & Generic
AQST
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and…
More →BCRX
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
More →BHC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of…
More →BIOA
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The…
More →CGC
Description unavailable
More →COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
More →